Current Oncology, Volume 20, Issue 3

When Pamela Fayerman received a grant of $20,000 from the Canadian Institutes of Health Research in 2012 to pursue health journalism research, she was able to travel throughout Canada to interview experts about a possible new way to prevent ovarian c...

This issue of Current Oncology contains four articles1–4 on the subject of the role of bilateral salpingectomy in preventing high-grade serous ovarian carcinoma.[...]

Although stimulated by more profound issues, Galilei’s quote could be applied to today’s changing understanding of the origin of ovarian carcinoma and how that knowledge might be used to prevent cancer.[...]

Ovarian cancer and associated fallopian tube and primary peritoneal cancers fall under a continuum of malignancies arising from the mullerian tract.[...]

Background: Most lung cancer patients experience multiple symptoms related either to the disease or its treatment. The commonly reported symptoms are pain, depression, anxiety, nausea, and poor well-being. The aim of the present study was to evaluate...

Purpose: Cancer patients face substantial care-related out-of-pocket (oop) costs that may influence treatment decisions, attitudes, and use of drug- or appointment-related cost-saving strategies. We examined the relationship between oop costs and car...

Introduction: In rectal cancer, decisions about the use of adjuvant and neoadjuvant treatment rely on clinical information from a variety of sources. Currently, the quality and accuracy of the aggregate of this clinical information is unclear. The ob...

Ovarian cancer is the fifth leading cause of cancer death among women in Canada, with an estimated 1750 deaths and 2600 new cases occurring in 20121.[...]

Background: Primary prophylaxis with granulocyte colony–stimulating factors (PP-G-CSF) is recommended in patients undergoing chemotherapy carrying a febrile neutropenia (FN) risk of 20% or more. In the present study, we examined clinical practice pat...

Background: Our retrospective study in breast cancer patients evaluated whether integrating subtype and pathologic complete response (pCR) information into axillary lymph node restaging after neoadjuvant chemotherapy (NAC) adds significance to its pr...